Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of leptin in regulating hepatic lipid metabolism in humans
2017-003014-22Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of metreleptin in lipodystrophy (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Leptin-induced changes in VLDL secretion. Started May 2018; status: completed.
02
Drugs
metreleptin
03
Conditions
lipodystrophy
Beyond the preview
Go deeper on 2017-003014-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003014-22.